Rupert Davies, Stanford L. Peng, Jason Lickliter, Kristi McLendon, Amanda Enstrom, Allison G. Chunyk, . . . Stacey R. Dillon. (2024). A first‐in‐human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults. Wiley.
Chicago Style (17th ed.) CitationRupert Davies, et al. A First‐in‐human, Randomized Study of the Safety, Pharmacokinetics and Pharmacodynamics of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Healthy Adults. Wiley, 2024.
MLA (9th ed.) CitationRupert Davies, et al. A First‐in‐human, Randomized Study of the Safety, Pharmacokinetics and Pharmacodynamics of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Healthy Adults. Wiley, 2024.
Warning: These citations may not always be 100% accurate.